PL1687297T3 - Dimery triazyny do leczenia chorób immunologicznych - Google Patents

Dimery triazyny do leczenia chorób immunologicznych

Info

Publication number
PL1687297T3
PL1687297T3 PL04818743T PL04818743T PL1687297T3 PL 1687297 T3 PL1687297 T3 PL 1687297T3 PL 04818743 T PL04818743 T PL 04818743T PL 04818743 T PL04818743 T PL 04818743T PL 1687297 T3 PL1687297 T3 PL 1687297T3
Authority
PL
Poland
Prior art keywords
treatment
autoimmune diseases
dimers
triazine
triazine dimers
Prior art date
Application number
PL04818743T
Other languages
English (en)
Inventor
Christopher Penney
Boulos Zacharie
Shaun D Abbott
Jean-François Bienvenu
Alan D Cameron
Jean-Simon Duceppe
Abdallah Ezzitouni
Daniel Fortin
Karine Houde
Nancie Moreau
Nicole Wilb
Brigitte Grouix
Lyne Gagnon
Original Assignee
Prometic Pharma Smt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma Smt Ltd filed Critical Prometic Pharma Smt Ltd
Publication of PL1687297T3 publication Critical patent/PL1687297T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL04818743T 2003-11-24 2004-11-22 Dimery triazyny do leczenia chorób immunologicznych PL1687297T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52402103P 2003-11-24 2003-11-24
EP04818743.9A EP1687297B1 (en) 2003-11-24 2004-11-22 Triazine dimers for the treatment of autoimmune diseases
PCT/CA2004/002003 WO2005049607A1 (en) 2003-11-24 2004-11-22 Triazine dimers for the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
PL1687297T3 true PL1687297T3 (pl) 2014-11-28

Family

ID=34619624

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04818743T PL1687297T3 (pl) 2003-11-24 2004-11-22 Dimery triazyny do leczenia chorób immunologicznych

Country Status (13)

Country Link
US (1) US7683061B2 (pl)
EP (1) EP1687297B1 (pl)
JP (1) JP5160788B2 (pl)
AU (1) AU2004291186B2 (pl)
BR (1) BRPI0416843A8 (pl)
CA (1) CA2554635C (pl)
DK (1) DK1687297T3 (pl)
ES (1) ES2501169T3 (pl)
IL (1) IL175814A0 (pl)
MX (1) MXPA06005879A (pl)
PL (1) PL1687297T3 (pl)
PT (1) PT1687297E (pl)
WO (1) WO2005049607A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2593578C (en) * 2005-01-07 2013-11-05 Emory University Cxcr4 antagonists for the treatment of medical disorders
CA2593612A1 (en) 2005-01-07 2006-07-13 Emory University Cxcr4 antagonists for the treatment of hiv infection
US20090075867A1 (en) 2005-05-19 2009-03-19 Lyne Gagnon Triazine compounds and compositions thereof for the treatment of cancers
WO2007128744A2 (en) * 2006-05-08 2007-11-15 Ciba Holding Inc. Triazine derivatives
EP2041067A4 (en) * 2006-07-11 2009-11-25 Univ Emory ANTAGONISTS OF CXCR4 COMPRISING DIAZINE AND TRIAZINE STRUCTURES FOR THE TREATMENT OF MEDICAL DISORDERS
US9510982B2 (en) 2010-01-13 2016-12-06 Ferno-Washington, Inc. Powered roll-in cots
CN103003264B (zh) 2010-05-21 2014-08-06 切米利亚股份公司 嘧啶衍生物
EP2688883B1 (en) 2011-03-24 2016-05-18 Noviga Research AB Pyrimidine derivatives
GB201119358D0 (en) * 2011-11-10 2011-12-21 Lewi Paulus J Disubstituted triazine dimers for treatment and/or prevention of infectious diseases
USD751000S1 (en) 2013-06-17 2016-03-08 Ferno-Washington, Inc. Control panel of a patient transport device having surface ornamentation
PL3068358T3 (pl) 2013-11-15 2019-03-29 Ferno-Washington, Inc. Nosze automatyczne
WO2015153936A2 (en) 2014-04-04 2015-10-08 Ferno-Washington, Inc. Methods and systems for automatically articulating cots

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544071A (en) * 1951-03-06 Diethylenetrimelamine and method
US2392607A (en) * 1946-01-08 Preparation of mono-aryl melamines
GB122458A (en) * 1918-01-22 1919-01-22 Regent Carriage Company Ltd Improvements in or relating to Strainers and like Devices for use on Aircraft.
BE707403A (pl) * 1966-12-03 1968-04-16
JPS4925501B1 (pl) * 1969-07-21 1974-07-01
IT1060458B (it) * 1975-12-18 1982-08-20 Chimosa Chimica Organica Spa Composti piperidil triazinici adatti per la stabilizzazione di polimeri sintetici e procedimento per la loro preparazione
US4269832A (en) * 1978-04-12 1981-05-26 American Cyanamid Company Method of treating arthritic disease
GB2053926B (en) * 1979-07-20 1983-02-23 Atkinson A Albumin extraction by affinity chromatography
FR2518106B1 (fr) * 1981-12-11 1986-12-05 Sandoz Sa Procede de teinture et d'impression de substrats organiques a l'aide de colorants directs bisazoiques
JPS58179263A (ja) * 1982-04-13 1983-10-20 Ube Ind Ltd 難燃性ポリアミド組成物
EP0101411B1 (de) * 1982-08-11 1989-01-25 Ciba-Geigy Ag Verfahren zur chemischen Bindung von Stabilisatoren an Polymere
DE3440777C2 (de) * 1983-11-14 1998-09-03 Clariant Finance Bvi Ltd Neue sulfonsäuregruppenhaltige, basische Azoverbindungen, deren Herstellung und Verwendung als Farbstoffe
JPS60260655A (ja) * 1984-06-06 1985-12-23 Mitsubishi Chem Ind Ltd ジスアゾ化合物及びセルロース繊維類用ジスアゾ反応性染料
JPS61225232A (ja) * 1985-03-29 1986-10-07 Adeka Argus Chem Co Ltd ポリオレフイン樹脂組成物
DE3518375C1 (de) * 1985-05-22 1986-07-17 Degussa Ag, 6000 Frankfurt Oxymethylencopolymerisat-Formmassen mit verminderter Formaldehyd-Emission bei der thermoplastischen Verarbeitung
JPS61272270A (ja) * 1985-05-28 1986-12-02 Mitsubishi Chem Ind Ltd ジスアゾ系化合物
JPH0619046B2 (ja) * 1985-12-06 1994-03-16 三菱化成株式会社 ジスアゾ化合物およびそれを含有する染料組成物
JPH07109526B2 (ja) * 1987-03-05 1995-11-22 日本化薬株式会社 電子写真用トナ−
JPH01154140A (ja) * 1987-12-11 1989-06-16 Fuji Photo Film Co Ltd 感光性マイクロカプセル及び感光材料
US4963461A (en) * 1987-10-02 1990-10-16 Fuji Photo Film Co., Ltd. Light-sensitive micropcapsule and light-sensitive material employing the same
GB8801486D0 (en) * 1988-01-22 1988-02-24 Ici Plc Water-soluble dye
ES2055151T3 (es) * 1988-03-16 1994-08-16 Ciba Geigy Ag Colorantes reactivos, procedimiento para su obtencion y utilizacion de los mismos.
US4972010A (en) * 1988-09-21 1990-11-20 Uniroyal Chemical Company, Inc. Substituted triazines
GB9016448D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
GB9016449D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
US5374301A (en) * 1990-07-26 1994-12-20 Zeneca Limited Inks suitable for use in ink jet printing
JPH04295860A (ja) * 1991-03-25 1992-10-20 Ricoh Co Ltd 画像形成方法
IT1252292B (it) * 1991-11-14 1995-06-08 Mini Ricerca Scient Tecnolog Policondensati melamminici
IT1252291B (it) * 1991-11-14 1995-06-08 Mini Ricerca Scient Tecnolog Composizioni polimeriche autoestinguenti
GB9220964D0 (en) * 1991-11-15 1992-11-18 Ici Plc Anionic compounds
CH684948A5 (de) * 1992-05-13 1995-02-15 Sandoz Ag Basische sulfogruppenhaltige Disazoverbindungen.
JP3210095B2 (ja) * 1992-10-13 2001-09-17 ハッコールケミカル株式会社 有機白色顔料
JPH06329933A (ja) * 1993-05-19 1994-11-29 Canon Inc 染料化合物、これを含有するインク、このインクを用いる記録方法、及び、かかるインクを用いた機器
US5631352A (en) * 1994-06-20 1997-05-20 Ciba-Geigy Corporation Azodyes containing a bridge member based on diamino-substituted triazines
JPH0895281A (ja) * 1994-09-29 1996-04-12 Canon Inc 記録紙及びこれを用いた画像形成方法
JPH10291365A (ja) * 1997-04-21 1998-11-04 Fuji Xerox Co Ltd 多色インクセット及びインクジェット記録方法
JPH1148609A (ja) * 1997-08-04 1999-02-23 Fuji Xerox Co Ltd 画像記録方法及び画像記録装置
EP1017744B1 (en) * 1997-09-27 2002-12-04 Clariant Finance (BVI) Limited Bridged monoazo compounds
WO1999021922A1 (en) * 1997-10-24 1999-05-06 Avecia Limited Disazodyes for ink jet printing
GB9820176D0 (en) * 1998-09-16 1998-11-11 Zeneca Ltd Inks
GB9929318D0 (en) * 1999-12-10 2000-02-02 Prometic Biosciences Limited Macrocyclic compounds and their use
US6153365A (en) * 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing compositions containing stain reducing agent
WO2001047921A1 (en) * 1999-12-28 2001-07-05 Pharmacopeia, Inc. Pyrimidine and triazine kinase inhibitors
JP5142432B2 (ja) * 2000-08-08 2013-02-13 キヤノン株式会社 蛍光インク、インクジェット記録方法、記録ユニット、インクカートリッジ、インクジェット記録装置、蛍光増強方法及び蛍光の長寿命化方法
CN1203328C (zh) * 2000-12-14 2005-05-25 富士胶片株式会社 基本上无色且光学各向异性的材料
JP4139558B2 (ja) * 2000-12-27 2008-08-27 富士フイルム株式会社 ビストリアジニルアリーレンジアミン誘導体とジアミノスチルベン誘導体とを含有する写真処理組成物及び画像形成方法
JP2002275397A (ja) * 2001-03-16 2002-09-25 Canon Inc インクセット、それを用いたインクジェット記録方法、記録ユニット、インクカートリッジ、及びインクジェット記録装置

Also Published As

Publication number Publication date
EP1687297A4 (en) 2009-04-22
MXPA06005879A (es) 2007-01-26
PT1687297E (pt) 2014-09-18
BRPI0416843A (pt) 2007-02-13
AU2004291186B2 (en) 2012-01-19
JP2007512259A (ja) 2007-05-17
EP1687297B1 (en) 2014-06-18
AU2004291186A1 (en) 2005-06-02
WO2005049607A1 (en) 2005-06-02
JP5160788B2 (ja) 2013-03-13
IL175814A0 (en) 2006-10-05
BRPI0416843A8 (pt) 2019-01-02
WO2005049607B1 (en) 2005-07-14
ES2501169T3 (es) 2014-10-01
EP1687297A1 (en) 2006-08-09
US7683061B2 (en) 2010-03-23
CA2554635A1 (en) 2005-06-02
DK1687297T3 (da) 2014-09-22
US20070149528A1 (en) 2007-06-28
CA2554635C (en) 2013-06-18

Similar Documents

Publication Publication Date Title
IL175814A0 (en) Triazine dimers for the treatment of autoimmune diseases
EP1613308A4 (en) CANCER TREATMENT METHODS
PL375532A1 (pl) Związki benzimidazol-1-ilotiofenowe do leczenia nowotworów
IL174014A0 (en) Methods for the treatment of endometriosis
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
EP1599196A4 (en) ANTICANCER THERAPY
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
EP1789034A4 (en) COMPOUNDS HAVING A DIPHENYL STRUCTURE FOR THE TREATMENT OF IMMUNE DISEASES
GB0329874D0 (en) Compounds useful for the treatment of diseases
AU2003298911A8 (en) Cyclosporins for the treatment of autoimmune diseases
GB0320238D0 (en) Treatment of disease
EP1611120A4 (en) NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
PL377601A1 (pl) Sposoby przewidywania zachowania samobójczego podczas leczenia
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0319182D0 (en) Medical headlight
GB0201025D0 (en) The treatment of degenerative diseases
ZA200606780B (en) Compounds for the treatment of diseases
GB0515544D0 (en) Limb bath
EP1648469A4 (en) ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF CATATONIA
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0325957D0 (en) The treatment of pain
GB0210210D0 (en) Treatment of hydrocarbons
GB0315877D0 (en) Compounds for the treatment of disease
HU0302933D0 (en) Treatment of diseases